Cargando…
Increased AURKA Gene Copy Number Correlates with Poor Prognosis and Predicts the Efficacy of High-dose Interferon Therapy in Acral Melanoma
Background: AURKA kinase is an essential serine/threonine kinase for mitosis and chromosome stability. The aberrant amplification and overexpression of AURKA are commonly observed in various types of cancer, including cutaneous melanoma. However, the status and the clinical significance of AURKA cop...
Autores principales: | Yan, Junya, Yu, Jiayi, Wu, Xiaowen, Xu, Tianxiao, Yu, Huan, Dai, Jie, Ma, Meng, Tang, Huan, Xu, Longwen, Chi, Zhihong, Si, Lu, Sheng, Xinan, Cui, Chuanliang, Kong, Yan, Guo, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907675/ https://www.ncbi.nlm.nih.gov/pubmed/29675108 http://dx.doi.org/10.7150/jca.24013 |
Ejemplares similares
-
TERT copy gain predicts the outcome of high-dose interferon α-2b therapy in acral melanoma
por: Yu, Sifan, et al.
Publicado: (2018) -
High G2 and S‐phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis
por: Xu, Tianxiao, et al.
Publicado: (2018) -
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose Interferon
por: Yu, Jiayi, et al.
Publicado: (2017) -
Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients
por: Yu, Jiayi, et al.
Publicado: (2018) -
Potential Mutations in Uveal Melanoma Identified Using Targeted Next-Generation Sequencing
por: Yu, Jiayi, et al.
Publicado: (2019)